Adaptive Designs for Clinical Trials offer a powerful tool to dramatically cut the cost, the time commitment and the potential for failure of trials, while maintaining the integrity and quality of the data collected. This conference is aimed at exploring the potential of adaptive trials now and in the future through looking at the whole process, from design through to implementation.

You will hear presentations from the key players in the adaptive arena on the big questions in adaptive design. Is an adaptive design suitable for my needs? What is the regulatory position on adaptive design? How do I build in adaption to my design? Will a seamless design prove any benefit? How do you manage the additional challenges of data collection, storage and manipulation? Where is the future for adaptive designs?

By attending this conference, you will be able to learn from the experiences of some of the biggest pharmaceutical companies in the world – there will be case studies from GlaxoSmithKline, Abbott Laboratories, Novartis, AstraZeneca, Sanofi-Aventis and Cephalon.